Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dopamine vs Norepinephrine in Septic Shock
NCT00604019Phase 3Completed
- Sponsor
- Rush University Medical Center
- Start
- Mar 2003
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of norepinephrine in septic shock (2 arms), sponsored by Rush University Medical Center. Primary endpoint: All-cause Mortality at 28 days. Started Mar 2003; status: completed.
02
Drugs
norepinephrine
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT00604019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00604019.